138 related articles for article (PubMed ID: 16616974)
21. Relationship between virulence factor genes in bovine Staphylococcus aureus subclinical mastitis isolates and binding to anti-adhesin antibodies.
Scarpa M; Piccinini R; Brun P; Grillo A; Palù G; Mengoli C; Daprà V; Castagliuolo I; Zecconi A
J Dairy Res; 2010 May; 77(2):159-67. PubMed ID: 20030902
[TBL] [Abstract][Full Text] [Related]
22. A novel peptide isolated from phage library to substitute a complex system for a vaccine against staphylococci infection.
Yang G; Gao Y; Dong J; Xue Y; Fan M; Shen B; Liu C; Shao N
Vaccine; 2006 Feb; 24(8):1117-23. PubMed ID: 16359760
[TBL] [Abstract][Full Text] [Related]
23. DNA-protein immunization against the GapB and GapC proteins of a mastitis isolate of Staphylococcus aureus.
Kerro-Dego O; Prysliak T; Potter AA; Perez-Casal J
Vet Immunol Immunopathol; 2006 Sep; 113(1-2):125-38. PubMed ID: 16777237
[TBL] [Abstract][Full Text] [Related]
24. Experimental trial in heifers vaccinated with Staphylococcus aureus avirulent mutant against bovine mastitis.
Pellegrino M; Giraudo J; Raspanti C; Nagel R; Odierno L; Primo V; Bogni C
Vet Microbiol; 2008 Feb; 127(1-2):186-90. PubMed ID: 17869031
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the humoral immune response in BALB/c mice immunized with a naked DNA vaccine anti-methicillin-resistant Staphylococcus aureus.
Roth DM; Senna JP; Machado DC
Genet Mol Res; 2006 Aug; 5(3):503-12. PubMed ID: 17117366
[TBL] [Abstract][Full Text] [Related]
26. Improved protective efficacy of a chimeric Staphylococcus aureus vaccine candidate iron-regulated surface determinant B ( N 126- P 361) -target of RNAIII activating protein in mice.
Yu L; Wang N; Ma J; Tong C; Song B; Chi J; Ma G; Zhu Z; Cui Y
Microbiol Immunol; 2013 Dec; 57(12):857-64. PubMed ID: 24117875
[TBL] [Abstract][Full Text] [Related]
27. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity.
Nilsson IM; Verdrengh M; Ulrich RG; Bavari S; Tarkowski A
J Infect Dis; 1999 Oct; 180(4):1370-3. PubMed ID: 10479175
[TBL] [Abstract][Full Text] [Related]
28. The influence of adhesive and invasive properties of Staphylococcus aureus defective in fibronectin-binding proteins on secretion of interleukin-6 by human endothelial cells.
Söderquist B; Alriksson I; Källman J; Kihlström E
APMIS; 2006 Feb; 114(2):112-6. PubMed ID: 16519747
[TBL] [Abstract][Full Text] [Related]
29. Virulence potential of the staphylococcal adhesin CNA in experimental arthritis is determined by its affinity for collagen.
Xu Y; Rivas JM; Brown EL; Liang X; Höök M
J Infect Dis; 2004 Jun; 189(12):2323-33. PubMed ID: 15181582
[TBL] [Abstract][Full Text] [Related]
30. Study of the humoral immunological response after vaccination with a Staphylococcus aureus biofilm-embedded bacterin in dairy cows: possible role of the exopolysaccharide specific antibody production in the protection from Staphylococcus aureus induced mastitis.
Prenafeta A; March R; Foix A; Casals I; Costa L
Vet Immunol Immunopathol; 2010 Apr; 134(3-4):208-17. PubMed ID: 19836084
[TBL] [Abstract][Full Text] [Related]
31. Staphylococcus aureus fibronectin-binding proteins (FnBPs). Identification of antigenic epitopes using polyclonal antibodies.
Rozalska B; Sakata N; Wadström T
APMIS; 1994 Feb; 102(2):112-8. PubMed ID: 8167006
[TBL] [Abstract][Full Text] [Related]
32. Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle.
Chang BS; Moon JS; Kang HM; Kim YI; Lee HK; Kim JD; Lee BS; Koo HC; Park YH
Vaccine; 2008 Apr; 26(17):2081-91. PubMed ID: 18387721
[TBL] [Abstract][Full Text] [Related]
33. Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice.
Yi SQ; Zhang XY; Yang YL; Yang Y; Liu SL; Fu L; Yu CM; Chen W
Microbiol Immunol; 2012 Jun; 56(6):406-10. PubMed ID: 22420921
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the opsonic activity of purified bovine sIgA following intramammary immunization of cows with Staphylococcus aureus.
Barrio MB; Rainard P; Gilbert FB; Poutrel B
J Dairy Sci; 2003 Sep; 86(9):2884-94. PubMed ID: 14507024
[TBL] [Abstract][Full Text] [Related]
35. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
Hu DL; Omoe K; Sasaki S; Sashinami H; Sakuraba H; Yokomizo Y; Shinagawa K; Nakane A
J Infect Dis; 2003 Sep; 188(5):743-52. PubMed ID: 12934191
[TBL] [Abstract][Full Text] [Related]
36. [GAPDH activity and immunogenicity of Staphylococcus aureus recombinant GapC protein].
Zhu H; Zhu Z; Cui Y; Zhang J; Liu L; Piao F
Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):754-9. PubMed ID: 18724693
[TBL] [Abstract][Full Text] [Related]
37. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
Josefsson E; Hartford O; O'Brien L; Patti JM; Foster T
J Infect Dis; 2001 Dec; 184(12):1572-80. PubMed ID: 11740733
[TBL] [Abstract][Full Text] [Related]
38. IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infection.
Narita K; Asano K; Nakane A
Med Microbiol Immunol; 2017 Jun; 206(3):225-234. PubMed ID: 28378247
[TBL] [Abstract][Full Text] [Related]
39. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
40. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.
Zhang BZ; Hua YH; Yu B; Lau CC; Cai JP; Zheng SY; Yam WC; Kao RY; Sze KH; Zheng BJ; Yuen KY; Huang JD
Infect Immun; 2015 Jan; 83(1):339-45. PubMed ID: 25368117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
